Utah Medical Products Profit Margin

Utah Medical Products (UTMD) currently reports a profit margin of 30.48% as of September 2026. That compares with 30.08% in the prior-year period — up 1.3% year over year. That is above the Healthcare sector average of 21.34%. Use the charts on this page to explore Utah Medical Products's profit margin history and peer comparisons.

Utah Medical Products's profit margin increased from 30.08% to 30.48% — a 1.3% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Utah Medical Products's profit margin of 30.48% is higher than the Healthcare sector average of 21.34%. That is roughly 42.9% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Utah Medical Products's current 30.48% should be judged against Healthcare norms (sector average: 21.34%) and against UTMD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 30.48%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.34%. From there, open related valuation or income-statement pages for Utah Medical Products, and consider following UTMD for alerts when major investors trade the stock.